0001209191-12-018573.txt : 20120315
0001209191-12-018573.hdr.sgml : 20120315
20120315174704
ACCESSION NUMBER: 0001209191-12-018573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120313
FILED AS OF DATE: 20120315
DATE AS OF CHANGE: 20120315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Timothy M
CENTRAL INDEX KEY: 0001375211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 12695224
MAIL ADDRESS:
STREET 1: 345 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6176795500
MAIL ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-03-13
0
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001375211
Sullivan Timothy M
C/O IDERA PHARMACEUTICALS, INC.
167 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
VP Development Programs
Stock Option (Right to Buy)
1.157
2012-03-13
4
A
0
9375
0.00
A
2021-11-28
Common Stock
9375
84375
D
On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 150,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On March 13, 2012, certain performance vesting criteria were met with respect to 9,375 of such shares, of which 2,343 shares vested on March 13, 2012 and the remaining 7,032 of which will vest in three equal annual installments beginning on March 13, 2013.
/s/ Timothy M. Sullivan
2012-03-15